Symmetrical anhydride-type serine protease inhibitors: Structure- activity relationship studies of human chymase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 3, 1999, Pages 413-418

  Iijima, Kiyoko ^a   Katada, Jun ^a   Hayashi, Yoshio ^a  

^a NIPPON STEEL CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID ANHYDRIDE; CHYMASE; CHYMASE INHIBITOR; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; COMPETITIVE INHIBITION; DRUG BINDING; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; ENZYME ACTIVE SITE; ENZYME ACTIVITY; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

AMINO ACIDS; CHYMASES; HUMANS; KINETICS; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033535116     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00012-8     Document Type: Article

References (16)

1. Lagunoff, D.; Benditt, E. P. Ann. NY Acad. Sci., 1963, 103, 185.
2. Schechter, N. M.; Fräki, J.E.; Geesin, J. C.; Lazarus, G.S. J. Biol. Chem. 1983, 258, 2973.
3. Okunishi, H.; Miyazaki, M.; Okamura, T.; Toda, N. Biochem. Biophys. Res. Commun. 1987, 149, 1186.
4. Urata, H.; Kinoshita, A.; Misono, K. S.; Bumpus, F. M.; Husain, A. J. Biol. Chem. 1990, 265, 22348.
5. Baek, D.-J.; Reed, P. E.; Daniels, S. B.; Katzenellenbogen, J. A. Biochemistry 1990, 29, 4305.
6. Moorman, A. R.; Abeles, R. H. J. Am. Chem. Soc. 1982, 104, 6785.
7. Hernandez, M. A.; Powers, J. C.; Glinski, J.; Oleksyszyn, J.; Vijayalakshmi, J.; Meyer, Jr. E. F. J. Med. Chem. 1992, 35, 1121.
8. Ito, K.; Igarashi, K.; Muramatsu, M.; Harada, T.; Hayashi, Y.; Katada, J.; Uno, I. Biochem. Biophys. Res. Commun. 1997, 240, 850.
9. Hayashi, Y.; Katada, J.; Harada, T.; Tachiki, A.; Iijima, K.; Takiguchi, Y.; Muramatsu, M.; Miyazaki, H.; Asari, T.; Okazaki, T.; Sato, Y.; Yasuda, E.: Yano, M.; Uno, I.; Ojima, I. J. Med. Chem. 1998, 41, 2345.
10. Ha, D.; Hart, D. J.; Yang, T. J. Am. Chem. Soc. 1984, 106, 4819.
11. PyBroP reagent; Bromo-tris-pyrrolidino-phosphonium hexafluorophosphate. Coste, J.; Dufour, M.-N.; Pantaloni, A.; Castro, B. Tetrahedron Lett. 1990, 31, 669.
12. Enzyme assay; The inhibitory effects of each compound on the enzymatic activities of five serine proteases were evaluated using the purified enzymes and chromogenic substrates. The enzymes and those substrates used here were as follow, N-succinyl-Ala-Ala-Pro-Phe-pNA (1.5 mM) for human recombinant chymase and bovine pancreatic α-chymotrypsin (Sigma Type I-S; 47 ng/mL); N-succinyl-Ala-Ala-Pro-Phe-pNA (3 mM) for human leukocyte cathepsin G (Elastin Products Co., Inc.; 2.5 U/mL); N-succinyl-Ala-Ala-Ala- pNA (1 mM) for porcine pancreatic elastase (Sigma Type III; 0.8 mg/mL); Bz-L-Arg-pNA (1 mM) for porcine pancreatic trypsin (Wako Pure Chemicals; 1 U/mL). All experiments were carried out using 50 mM HEPES buffer (pH 7.4) containing 0.1 mM NaCl, except for the buffer used for chymase, which contained 50 mM Tris-HCl (pH 8.0) and 1 M KCl.
13. Each enantiomer of 2,2-dimemyl-3-(N-benzoyl)amino-5-phenylpentanoic acid was isolated by HPLC using chiral column (CHIRALCEL OD, 10 × 250 mm) eluted with a mixture of hexane and 2-propanol (3:1) and was used for the anhydride formation according to the procedure shown in Scheme 1.
14. D = +51.0° (c 0.25, MeOH).
15. Takai, S.; Shiota, N.; Yamamoto, D.; Okunushi, H.; Miyazaki, M. Life Sci. 1996, 58, 591.
16. Hart, G. J.; O'Brien, R. D. Biochemistry 1973, 12, 2940.